Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
abscess, sphenoid sinus
acetaminophen
acetylcysteine
acquired immunodeficiency syndrome
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, relapsing
acute toxic leukoencephalopathy
acyclovir
adalimumab
addiction, heroin
addiction, heroin-neurologic complications with
advances in neurology
adverse drug reaction
Africa
age associated memory impairment
agenesis of corpus callosum
akinetic mute
Alberta Stroke Program Early CT score
alcohol, neurologic complications with
alemtuzumab
algorithm
alternating hemiplegia
alternating hemiplegia of childhood
Alzheimer's disease
Alzheimer's disease, treatment of
aminoglycoside
ammonia
amphetamines
amphotericin B
Amplatzer device
amygdala
amyloid angiopathy, cerebral
amyloidosis
amyloid-related imaging abnormalities
anaphylaxis
anatomy of
anemia
aneurysm
aneurysm clip
aneurysm, intracranial, treatment of
angiitis, isolated of CNS, benign focal
angiography, cerebral, beaded vessels
angiography, cerebral
angiography, cerebral, negative
angiography, cerebral, reversible abnormality
anterior cerebral artery, occlusion of
antibiotics
antibiotics, neurologic complications with
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
anticonvulsants, blood level determination of
anticonvulsants, cognitive function with
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, untoward effects of
antidepressant
antihypertensive
antiparasitic therapy
antisense therapy
antiviral agents
aphasia
apixaban
apolipoprotein E
apoliprotein E, plasma level
apraxia, constructional
arrhythmia, cardiac
arterial dissection
arterial dissection, carotid
arterial dissection, vertebral
arteriopathy
arteritides
arthralgia
aspirin
asymptomatic
ataxia
ataxia, cerebellar
ataxic gait
atrial fibrillation
atypical
autoantibodies
autoimmune disease
autoimmune encephalopathy
Ayurvedic medicine
azidodeoxythymidine
B cell lymphocyte depletion
B cell lymphocytes
Babinski sign
bacterial infection
barbiturate
baroreceptors
basal ganglia
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
benign essential tremor
benzodiazepine
bevacizumab
binge drinking
biologic markers
bitemporal visual field defect
blindness
blood pressure
bone marrow transplantation
bortezomib
brachium pontis
bradycardia
bradykinesia
brain atrophy
brain biopsy
brain purpura
brainstem
brainstem, infarction of
brainstem, lesion of
bridge therapy
bromocriptine
burning legs
burning paresthesia
burning skin
busulfan
cabergoline
calcification, intracranial
calcium antagonist
Call-Fleming syndrome
Canavan's disease
cancer of colon
cancer, cerebrovascular accident complicating patients with
capecitabine
carbamazepine
carbon monoxide poisoning
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of thyroid
cardiac transplantation
cardiomyopathy
cardioseal device
carmofur
carotid artery disease
carotid artery occlusion, intracranial
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, chest
CAT scan, complication with
CAT scan, contrast enhanced
CAT scan, delta sign, empty
CAT scan, early changes in CVA
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, myelogram with
CAT scan, perfusion
CAT scan, ring sign
Cat scan, sinus
CAT scan, spinal cord
cauda equina, lesion of
cavernous sinus, thrombosis
CD4 counts
central nervous system, infection of
centrum semiovale
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar edema
cerebellar hemorrhage
cerebellar lesion
cerebellar vermis
cerebellitis
cerebellitis, autoimmune
cerebellum
cerebral atherosclerosis
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, cytotoxic
cerebral edema, vasogenic
cerebral embolism, mechanical extraction
cerebral hypersensitivity, delayed
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, leak
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, age of lesion
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, circadian rhythm
cerebrovascular accident, cryptogenic
cerebrovascular accident, etiology
cerebrovascular accident, mimics
cerebrovascular accident, misdiagnosis
cerebrovascular accident, multiple
cerebrovascular accident, postpartum
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, silent
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to MRI after
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, young adult
cerebrovascular disease
chemonecrosis
chemotherapy, CNS treatment and complications with
chest x-ray, abnormal
chiasmal syndromes
children
chloral hydrate
chorea
choreoathetosis
cilostazol
cingulate island sign
circadian rhythm
cirrhosis
cisternogram, gadolinium
cladribine
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clopidogrel
clot retrieval
cluster headache
cocaine
Cogan's syndrome
cognition
collateral circulation
coma
complications
conduction block
confusion
congenital malformation
conjugate gaze, forced
contractures, joint
contraindications
contrast agent
contrast agents, neurotoxicity of
controversies in neurology
cop 1
copper deficiency
corpus callosum
corpus callosum, lesion of
cortical blindness
cortical blindness, transient
cost
cost effectiveness
counselling
cranial nerve enhancement
cranial nerve palsies
cranial neuropathy
creatine phosphokinase(CPK)elevated
creatinine, elevated
cyclophosphamide
cyclosporine
cysticercosis
cysticercosis, cerebral
cytokines
cytosine arabinoside
cytotoxic lesions of the corpus callosum
dabigatran
daclizumab
DAWN stroke trial
deep gray nuclei
defecation
degenerative diseases of CNS
delay in diagnosis
delirium
delusion
dementia
dementia, rapidly progressive
dementia, reversible
demyelinating disease
dental implants
dental prostheses
dentate nuclei
dentate nuclei, lesion of
denture cream
desmoteplase
developmental abnormality of brain
diabetes insipidus
diagnostic criteria
dialysis
diencephalon
dietary supplement
differential diagnosis
difficulty climbing stairs
digital subtraction angiography
dilantin
diplopia
disability rating scale, neurological
disability, neurological
disorientation
disulfiram
donepezil
door to needle time
dopamine agonist
down-beat nystagmus
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug induced neurologic disorders in children
drug interactions
drug overdose
drug overdose, accidental
drug withdrawal
dural leak
dural sinus thrombosis
dysarthria
dyslexia
dysmetria
dysphasia
dystonia
dystroglycanopathies
Echinacea
echocardiogram
echocardiogram, transesophageal
eclampsia
eclampsia, postpartum
efficacy
electrocardiogram, abnormal
electroencephalogram, abnormalities of
electromyogram
embolism, paradoxical
emergencies, medical
emergencies, neurologic
emergencies, ocular
emergency room
Emery-Dreifuss muscular dystrophy
encephalitis
encephalitis, autoimmune
encephalitis, viral
encephalomyelitis, postinfectious
encephalopathy
encephalopathy, acute
encephalopathy, delayed
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
eosinophilia
ephedrine
epidemiology of neurology
erectile dysfunction
ergonovine
ergotamine
ergotism
erythromelalgia
erythropoietin
erythropoietin treatment
ESCAPE trial
etanercept
evidence-based research
excitotoxin
exercise
EXTEND trial
extralimbic encephalitis
facial nerve palsy
faciobrachial dystonic seizure
factor Xa inhibitor
Fahr disease
failed back syndrome
failed medical management
falling
fatigue
fetus
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, exclusion criteria
fibrinolytic agents, intra-arterial local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fingolimod
fistula, arterio-venous, dural
fludarabine
fluorouracil
frexalimab
fumarate
gadobutrol
gadolinium
gait disorder
gammaglobulin therapy, intravenous
gangrene
gantenerumab
gastric partitioning
gastrointestinal bleeding
gemcitabine
gender
gene
gene mutation
gene therapy
genetic neurologic disorders
glioblastoma multiforme(astrocytoma Gr.III)
glioma
glioma, low-grade
globus pallidus
globus pallidus, hemorrhage
globus pallidus, lesion of
globus pallidus, lesion of, bilateral
glutamic acid decarboxylase, antibody
glutaric acidemia
granulomatous disease
granulomatous hypophysitis
Guillain Barre syndrome
hallucination
hallucination, visual
head injury
headache
headache, bifrontal
headache, occipital
headache, precipitating factors
headache, recurrent
headache, severe
headache, sinus
headache, thunderclap
headache, treatment of
headache, worst of life
hearing loss
hearing loss, bilateral
heart valve, prosthetic
hemiparesis
hemiplegia
hemosiderosis, subarachnoid
hepatic encephalopathy
hepatic encephalopathy, acute
hepatic failure
hepatic failure, acute
hepatolenticular degeneration(Wilson's disease)
hepatosplenomegaly
heralding manifestation
herbs
herniated disc
herniated disc, lumbar
herniation syndromes, intracranial
herpes simplex encephalitis
herpes simplex encephalitis, atypical
herpes simplex virus infection, immunosuppressed patient
herpes virus infection
herpes zoster
herpes zoster, disseminated
highly active antiretroviral therapy
human immunodeficiency virus type 1
Hurler's syndrome
hydrocephalus
hydrocephalus, congenital
hydrocephalus, fetal
hyperammonemic encephalopathy
hypereosinophilic syndrome(HES)
hyperreflexia
hypersensitivity reaction
hypertension
hypertrophic intracranial pachymeningitis
hyperviscosity
hypoglycorrhachia
hypogonadism
hyponatremia
hypotension, systemic
hypotonia
hypoxia
iatrogenic neurologic disorders
idarucizumab
idiopathic
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunization, neurologic complications with
immunologic disease
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
implantable cardioverter defibrillator
inattention
infection
infliximab
insect sting
intellectual deterioration
intelligence testing in children
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interleukin 2
internal capsule
internal carotid artery
internuclear ophthalmoplegia
intracerebral hemorrhage
intracerebral hemorrhage, awakening with
intracerebral hemorrhage, lobar
intracerebral hemorrhage, multiple
intracerebral hemorrhage, small
intracranial hemorrhage
intracranial hypotension
intracranial pressure, increased
intrathecal chemotherapy
intrathecal gadolinium
intrauterine
ipilimumab
iron, brain
ischemic core
ischemic penumbra
JC virus
laminectomy
laminectomy, lumbar
laquinimod
lateropulsion
L-dopa
L-dopa, drug interactions with and side effects of
lecanemab
leg weakness, bilateral
Leigh's disease
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
lentiform fork sign
lenvatinib
lethargy
leucine rich glioma inactivated 1 antibodies
leukemia
leukemia, neurologic findings assoc.with
leuko-araiosis
leukodystrophy
leukoencephalopathy
leukoencephalopathy, acute
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
leukopenia
levamisole
level of consciousness, decreased
Lewy body
Lewy body disease, diffuse
libido
libido, decreased
life expectancy
limb ischemia
limbic encephalitis
linomide
lisuride
liver function enzymes
liver transplantation
locus ceruleus, lesion of
low back pain
lumbar puncture, indications for
lymphadenopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
lymphopenia
lysosomal storage disease
macular edema
magnetic susceptibility
malabsorption
malabsorption syndrome
malaria
malformation, CNS, congenital
malpractice
maple syrup urine disease
marihuana
McDonald criteria for MS
medical-legal aspects of neurology
melanoma, malignant
memory, impairment of
memory, impairment of, subjective
Meniere's disease
meningeal diverticula
meningeal enhancement
meningeal enhancement, nodular
meningismus
meningitis
meningitis, aseptic
meningitis, drug induced
meningoencephalitis
mental status, abnormal
MERCI trial
MERS
mesial temporal lobe
metabolic acidosis
metformin
methadone
methotrexate
metoclopramide
metronidazole
microhemorrhage, intracerebral
midbrain, lesion of
middle cerebral artery
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
migraine
migraine, pregnancy
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
mimics
miosis
misdiagnosis
mitochondrial disease
molecular genetics
monoclonal antibodies
morphine
mortality
motor cortex
movement disorder
movement disorder, treatment of
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, abnormal, seizure causing
MRI, ADC maps
MRI, angiography
MRI, angiography, false negative
MRI, artifacts
MRI, brain tumors
MRI, cardiac
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, cisternogram
MRI, complications with
MRI, contraindications
MRI, contrast enhanced
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, early changes in CVA
MRI, emergent
MRI, false negative
MRI, fetal
MRI, FLAIR
MRI, gradient-echo
MRI, high signal foci on
MRI, high signal intensity of basal ganglia
MRI, indications for
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, muscle
MRI, myelogram
MRI, negative
MRI, nodular enhancement
MRI, optic nerve
MRI, paramagnetic effect
MRI, perfusion
MRI, ring sign
MRI, ring sign, open
MRI, safety
MRI, serial
MRI, spinal cord
MRI, spinal cord, increased intramedullary cord signal
MRI, spine
MRI, susceptibility weighted
MRI, T1 weighted high signal foci
MRI, venography
MRI, volumetry
MRS
mucopolysaccharidoses
multimodal neuroimaging
multiple organ failure
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, aggressive
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, tumefactive
muscle biopsy
muscle pain
muscle weakness
muscular dystrophy
muscular dystrophy, cardiovascular changes with
muscular dystrophy, central nervous system abnormality
muscular dystrophy, classification
muscular dystrophy, congenital
muscular dystrophy, Duchenne
muscular dystrophy, facioscapulohumeral
muscular dystrophy, limb-girdle
mutism
myasthenia gravis
mycophenolate
mycosis fungoides
myelitis
myelitis, longitudinal
myelitis, transverse
myelogram
myelopathy
myelopathy, chronic progressive
myoclonus
myopathy
myopathy, autoimmune
myopathy, drug-induced
myopathy, necrotizing
myopathy, necrotizing, autoimmune
myopathy, necrotizing, immune-mediated
myositis
nasal decongestant
natalizumab
natalizumab, discontinuation
nattokinase
nausea and vomiting
neck stiffness
negative
neoplasm, intracranial-incidence and epidemiology of
neoplasm, metastatic
neoplasm, metastatic to CNS
neoplasm, pituitary
neoplasm, primary intracerebral
neoplasm, primary intracerebral, resection
neoplasm, primary of CNS
neoplasm, primary of CNS-recurrent
neoplasm, primary of CNS-treatment of
nephritis
nephrogenic systemic fibrosis
nerve biopsy
nerve conduction studies
neuritis, causes of
neuroendocrinology
neurofilament light chain protein
neuroleptic
neuroleptic sensitivity
neurologic complications
neurologic complications of, systemic cancer
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic testing
neuromuscular disease, electrodiagnosis of
neuroophthalmology
neurootology
neuropathology
neuropathy
neuroprotective agents
neuroradiology, interventional
neurotoxic
neurotoxicity, acute
neurotoxin
neutralizing antibodies
neutropenia
nicotine
nicotine patch
nigrostriatal pathway
nivolumab
nonsteroidal anti-inflammatory drug
non-vitamin K antagonist oral anticoagulants
number needed to treat
nutritional deficiency
nystagmus
nystagmus, direction changing
occipital lobe, infarction, bilateral
occipital lobe, lesion of
occupational neurologic disorders
ocrelizumab
ofatumumab
old age, neurology of
oligodendroglioma
opiate
opportunistic infection
opportunistic infection, CNS
optic chiasm
optic chiasm, herniation
optic disc edema
optic nerve, enhancement
optic neuritis
optic tract
oral contraceptives
organ transplantation
ototoxicity
oxycodone
pacemaker, cardiac-transvenous
pain, back
pallidotomy
paraparesis, spastic
paraplegia
parasitic infection, CNS
paresthesias
paresthesias, generalized
parietal lobe, atrophy
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, intractable
Parkinson disease, pathogenesis of
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
patent foramen ovale
patent foramen ovale, percutaneous closure
patent foramen ovale, surgical treatment of
patient information and support
patient selection
pediatric opioid use associated neurotoxicity
pembrolizumab
penicillamine
pericarditis
perimetry
peripheral pulse, absent
personality change
pheochromocytoma
photophobia
pituitary stalk
pituitary stalk, enlarged
pituitary, adenoma
pituitary, lesion of
placebo
platelet inhibiting drugs
platelet inhibiting drugs, combined
pleocytosis of cerebrospinal fluid
pleurisy
pneumonia
polycythemia, secondary
polymerase chain reaction
polymerase chain reaction, false negative
polyneuropathy, chronic inflammatory demyelinating
pons, infarction of
pons, lesion of
posterior cortical atrophy
posterior leukoencephalopathy syndrome
postpartum
postpartum cerebral angiopathy
poststroke recrudescence
potassium channel antibodies
practice guidelines
praziquantel
precipitating factors
pre-eclampsia
pregnancy, neurologic complications in
prenatal
prevention of neurologic disorders
primary intracranial hypotension
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
prolactin, elevated
prolactinoma
propofol
protease inhibitor, HIV-1
protocol violations
protozoan infection
pseudosubarachnoid hemorrhage
psoriatic arthritis
psychiatric disorder
psychiatric problems in neurologic disorders
psychological testing
psychomotor retardation
psychosis
quadriparesis
quadriparesis, progressive
quality of life
race
radiation encephalopathy, delayed
radiation necrosis
radiation therapy, CNS treatment and complications with
Rankin score
raphe nuclei
RAPID CT perfusion maps
rash
reading disorder, acquired
recanalization, arterial
receptor tyrosine kinase inhibitor
rechallenge
recombinant activated factor VII
recurrent
Red flags
references, neurologic
REM sleep behavior disorder
remote effect of cancer on the nervous system
remternetug
renal failure
renal failure, acute
reperfusion
respirator
respiratory failure
Retriever Device
REVASCAT trials
revascularization, surgical
reversible cerebral vasoconstrictive syndromes
reversible neurologic disorder
reversible splenial lesion syndrome
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
risk-benefit assessment
ritonavir
rituximab
rivaroxaban
safety
sarcoid-like reaction
sarcoidosis
sarcoidosis, CNS
sarcoma
sarcoma, osteogenic
screening
SEDAN score
sedation
seizure
seizure, adult onset
seizure, complications following
seizure, diagnosis of
seizure, differential diagnosis of
seizure, drug-induced
seizure, prevention of
seizure, psychomotor-temporal lobe
seizure, psychosocial aspects of
seizure, surgical treatment of
seizure, treatment of
selective serotonin reuptake inhibitors
sella turcica, enlargement of
sensory loss
serologic testing
serologic testing, false negative
sertraline
shunt procedure, ventricular
sickle cell disease
sildenafil
simultanagnosia
single photon emission computed tomography
sinuses, diseases of
sinusitis
skin, discoloration
skin, lesions in neurologic disorders
skin, thickened
skull fracture
skull fracture, pediatric
sleep pathology and physiology
sleeping sickness
sodium valproate
sodium valproate, toxicity
solitaire device
solvent
somatosensory evoked potentials
somnolence
sphenoid sinus
sphenoidotomy
spinal cord
spinal cord, infarction of
spinal cord, lesion of
spinal cord, vascular malformation of
splenium of corpus callosum
splenomegaly
STARFlex septal closure system
statin therapy
status epilepticus
status epilepticus, nonconvulsive
stem cell transplantation
stent, aneurysm repair
steroid
steroid therapy, CNS treatment and complications with
stillbirth
stimulation, deep brain
stroke protocol
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subarachnoid hemorrhage, nonaneurysmal
subdural hematoma
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
sulfonamides
superior sagittal sinus thrombosis
SWIFT PRIME Trials
symmetric brain lesions
sympathomimetic drugs
symptomatic
syncope
synucleinopathy
systemic illness
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
tacrolimus
tamoxifen
temporal lobe, lesion
temporal lobe, lesion, bilateral
tension headache
teriflunomide
testicular atrophy
thalamotomy
thalamus, focused ultrasound ablation
thalamus, lesion of
thalamus, lesion of-bilateral
thrombectomy
thrombocytopenia
thrombolysis, mechanical
tissue plasminogen activator antigen
tissue plasminogen activator, intravenous
toxic encephalopathy
toxins, nervous system
toxoplasma complement fixation test
toxoplasmosis, acquired
toxoplasmosis, CNS
transient ischemic attack
transient neurologic deficit
trauma
travel, foreign
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tremor, treatment of
Trevo retriever
trimethoprim-sulfamethoxazole
trypanosoma brucei gambiense
tsetse fly
tuberculin skin test, positive
tumefactive lesion
tumor necrosis factor
tumor necrosis factor inhibitor
ultrasonography
ultrasonography, head
uremia
urinary incontinence
urinary tract infection
vaccination, neurologic complications with
vaccine
vardenafil
varicella zoster virus
varicella zoster virus, encephalitis
varicella zoster virus, vasculopathy
variola
variola vaccination
vasculitides
vasculitides, benign cerebral
vasculopathy
vasoactive substances
vasoconstrictive drugs
vasospasm
vasospasm, cerebral
ventriculostomy
vertebral artery
vertebral artery disease
vertebral-basilar insufficiency
vertigo
vestibulopathy
vigabatrin
viral infection
viral infection, CNS
viral infection, reactivation
vision, blurred
visual acuity, decreased
visual field defect
visual fields
visual impairment
visual loss
visual loss, sudden-unilateral
visuospatial disturbance
WAKE-UP trial
walking, difficulty with
watershed infarcts
weakness
weakness, generalized
weakness, progressive
weakness, proximal
weightlifting
wheelchair
white matter disease
wide based gait
workup
zinc
Showing articles 100 to 150 of 8611 << Previous Next >>

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Safety of Thrombolysis in Patients Over the Age of 80
The Neuroogist 18:99-101, Willey,J.Z.,et al, 2012

Sildenafil-Induced Cervical Spinal Cord Infarction
AJNR 33:e32-e33, Walden,J.E. & Castillo,M., 2012

Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score
Ann Neurol 71:634-641, Strbian,D.,et al, 2012

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Iodinated Contrast Media and Cerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2170-2174, MacDougall, N.J.J.,et al, 2011

Efficacy and Safety of Combination Antiplatelet Therapies in Patients with Symptomatic Intracranial Atherosclerotic Stenosis
Stroke 42:2883-2890, Kwon, S.U.,et al, 2011

Acute Hepatic Encephalopathy: Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Findings, and Correlation With Plasma Ammonia Level and Clinical Outcome
AJNR 31:1471-1479, McKinney,A.M.,et al, 2010

Safety of tPA in Stroke Mimics and Neuroimaging-Negative Cerebral Ischemia
Neurol 74:1340-1345, 1336, Chernyshev,O.Y., et al, 2010

Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010

Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does not Increase the Risk of Contrast-Induced Nephropathy
AJNR 31:817-821, Lima,F.O., et al, 2010

Longitudinally Extensive Transverse Myelitis Following Vaccination With Nasal Attenuated Novel Influenza A (H1N1) Vaccine
Arch Neurol 67:1018-1020, Akkad,W., et al, 2010

Safety of Performing CT Angiography in Stroke Patients Treated With Intravenous Thrombolysis
JNNP 81:783-787, Aulick�,P., et al, 2010

Brain Microbleeds as a Potential Risk Factor for Antiplatelet-Related Intracerebral Haemorrhage: Hospital-Based, Case-Control Study
JNNP 81:679-684, Gregoire,S.M., et al, 2010

Diagnostic Yield of Double-Dose Gadobutrol in the Detection of Brain Metastasis: Intraindividual Comparison With Double-Dose Gadopentetate Dimeglumine
AJNR 31:1055-1058, Kim,E.S., et al, 2010

Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients
Stroke 41:1996-2000, Abou-Chebl,A.,et al, 2010

Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors
Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Methadone-Induced Toxic Leukoencephalopathy: MR Imaging and MR Proton Spectroscopy Findings
AJNR 31:565-566, Salgado,R.A.,et al, 2010

A 31-Year-Old Woman with a Transformed Low-Grade Glioma
JAMA 303:967-976, Warnke,P.C., 2010

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Spontaneous Isolated Convexity Subarachnoid Hemorrhage: Presentation, Radiological Findings, Differential Diagnosis, and Clinical Course
J Neurosurg 109:1034-1041, Refai, D.,et al, 2008

Clinical and Radiological Characteristics of Methotrexate-Induced Acute Encephalopathy in Pediatric Patients with Cancer
Ann Oncol 19:178-184, Inaba, H.,et al, 2008

Renal Safety of CT Angiography and Perfusion Imaging in the Emergency Evaluation of Acute Stroke
AJNR 29:1826-1829, Hopyan,J.J.,et al, 2008

Delayed Leukoencephalopathy with Stroke-Like Presentation in Chemotherapy Recipients
JNNP 79:535-539, Baehring,J.M. &Fulbright,R.K., 2008

Gadolinium-Enhanced MR Cisternography to Evaluate Dural Leaks in Intracranial Hypotension Syndrome
AJNR 29:116-121, Albayram,S.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008



Showing articles 100 to 150 of 8611 << Previous Next >>